The origins of oncomice: A history of the first transgenic mice genetically engineered to develop cancer

152Citations
Citations of this article
277Readers
Mendeley users who have this article in their library.

Abstract

This perspective describes the concurrent development in the 1980s of the first transgenic mice genetically engineered to express dominant oncogenes, involving independent researchers who were largely unaware of each other's strategies and progress. We relate the experimental designs, the pitfalls and challenges encountered, and the eventual success in developing distinctive mouse models of cancer, wherein tumors arose heritably in various organs. These early oncomice have produced a wealth of new knowledge, become topics of intellectual property, and spawned a vibrant field of cancer research that is revealing mechanisms of tumorigenesis and suggesting new therapeutic strategies for treating the human disease. © 2007 by Cold Spring Harbor Laboratory Press.

Cite

CITATION STYLE

APA

Hanahan, D., Wagner, E. F., & Palmiter, R. D. (2007, September 15). The origins of oncomice: A history of the first transgenic mice genetically engineered to develop cancer. Genes and Development. https://doi.org/10.1101/gad.1583307

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free